Literature DB >> 18817846

Reduced NGF level and TrkA protein and TrkA gene expression in the optic nerve of rats with experimentally induced glaucoma.

Valentina Sposato1, Massimo Gilberto Bucci, Marco Coassin, Matteo Antonio Russo, Alessandro Lambiase, Luigi Aloe.   

Abstract

Glaucoma (GL) is an optic neuropathy characterized by progressive loss of visual field due to retinal cell death and optic nerve (ON) degeneration, usually in response to abnormal elevated intraocular pressure (EIOP). It has previously demonstrated that cells of the ON express nerve growth factor (NGF) and NGF-receptors. Relatively little is known, however, about their role on the ON of the glaucomatous eye. The aim of the study was to elucidate this aspect. Using a rat model of GL we investigated the response of NGF and NGF-receptors in the ON of subjects with experimentally induced EIOP. Our results show that EIOP significantly impairs the presence of NGF and NGF-receptor proteins and TrkA gene expression in the ON of glaucomatous eye. These findings suggest that NGF and NGF-receptor might be important signals for the ON response in the EIOP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18817846     DOI: 10.1016/j.neulet.2008.09.024

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

1.  NGF/anti-VEGF combined exposure protects RCS retinal cells and photoreceptors that underwent a local worsening of inflammation.

Authors:  Maria Luisa Rocco; Bijorn Omar Balzamino; Graziana Esposito; Carla Petrella; Luigi Aloe; Alessandra Micera
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-12-24       Impact factor: 3.117

Review 2.  Neuroprotective therapies for glaucoma.

Authors:  Wei Song; Ping Huang; Chun Zhang
Journal:  Drug Des Devel Ther       Date:  2015-03-11       Impact factor: 4.162

Review 3.  Biomarkers of Neurodegeneration and Precision Therapy in Retinal Disease.

Authors:  Alessandra Micera; Bijorn Omar Balzamino; Antonio Di Zazzo; Lucia Dinice; Stefano Bonini; Marco Coassin
Journal:  Front Pharmacol       Date:  2021-01-18       Impact factor: 5.810

Review 4.  Nerve Growth Factor: A Focus on Neuroscience and Therapy.

Authors:  Luigi Aloe; Maria Luisa Rocco; Bijorn Omar Balzamino; Alessandra Micera
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

5.  Topical recombinant human Nerve growth factor (rh-NGF) is neuroprotective to retinal ganglion cells by targeting secondary degeneration.

Authors:  Li Guo; Benjamin M Davis; Nivedita Ravindran; Joana Galvao; Neel Kapoor; Nasrin Haamedi; Ehtesham Shamsher; Vy Luong; Elena Fico; M Francesca Cordeiro
Journal:  Sci Rep       Date:  2020-02-25       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.